These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9685423)

  • 1. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting.
    Kang S; Liang L; Parker CD; Collawn JF
    J Biol Chem; 1998 Aug; 273(32):20644-52. PubMed ID: 9685423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the structural requirements for lysosomal membrane targeting using transferrin receptor chimeras.
    White S; Hatton SR; Siddiqui MA; Parker CD; Trowbridge IS; Collawn JF
    J Biol Chem; 1998 Jun; 273(23):14355-62. PubMed ID: 9603944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain.
    Zaliauskiene L; Kang S; Brouillette CG; Lebowitz J; Arani RB; Collawn JF
    Mol Biol Cell; 2000 Aug; 11(8):2643-55. PubMed ID: 10930460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment.
    Odorizzi CG; Trowbridge IS; Xue L; Hopkins CR; Davis CD; Collawn JF
    J Cell Biol; 1994 Jul; 126(2):317-30. PubMed ID: 8034737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for major histocompatibility complex class II invariant chain trafficking in polarized Madin-Darby canine kidney cells.
    Odorizzi G; Trowbridge IS
    J Biol Chem; 1997 May; 272(18):11757-62. PubMed ID: 9115230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway.
    Pond L; Kuhn LA; Teyton L; Schutze MP; Tainer JA; Jackson MR; Peterson PA
    J Biol Chem; 1995 Aug; 270(34):19989-97. PubMed ID: 7650016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of interaction between leucine-based sorting signals from the invariant chain and clathrin-associated adaptor protein complexes AP1 and AP2.
    Kongsvik TL; Höning S; Bakke O; Rodionov DG
    J Biol Chem; 2002 May; 277(19):16484-8. PubMed ID: 11854303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-routing of the invariant chain to the direct sorting pathway by introduction of an AP3-binding motif from LIMP II.
    Gupta SN; Kloster MM; Rodionov DG; Bakke O
    Eur J Cell Biol; 2006 Jun; 85(6):457-67. PubMed ID: 16542748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of the leucine-based sorting motifs in the cytosolic tail of the major histocompatibility complex-associated invariant chain.
    Motta A; Bremnes B; Morelli MA; Frank RW; Saviano G; Bakke O
    J Biol Chem; 1995 Nov; 270(45):27165-71. PubMed ID: 7592972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis.
    Collawn JF; Lai A; Domingo D; Fitch M; Hatton S; Trowbridge IS
    J Biol Chem; 1993 Oct; 268(29):21686-92. PubMed ID: 8408022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the cytoplasmic tail of the human transferrin receptor. Identification of a sub-domain that is required for rapid endocytosis.
    Gironès N; Alverez E; Seth A; Lin IM; Latour DA; Davis RJ
    J Biol Chem; 1991 Oct; 266(28):19006-12. PubMed ID: 1918016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail.
    Pieters J; Bakke O; Dobberstein B
    J Cell Sci; 1993 Nov; 106 ( Pt 3)():831-46. PubMed ID: 8308066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
    Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
    Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
    Romagnoli P; Layet C; Yewdell J; Bakke O; Germain RN
    J Exp Med; 1993 Mar; 177(3):583-96. PubMed ID: 8436902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.
    Marks MS; Roche PA; van Donselaar E; Woodruff L; Peters PJ; Bonifacino JS
    J Cell Biol; 1995 Oct; 131(2):351-69. PubMed ID: 7593164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable components.
    Marks MS; Woodruff L; Ohno H; Bonifacino JS
    J Cell Biol; 1996 Oct; 135(2):341-54. PubMed ID: 8896593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase II activity is required for transferrin receptor endocytosis.
    Cotlin LF; Siddiqui MA; Simpson F; Collawn JF
    J Biol Chem; 1999 Oct; 274(43):30550-6. PubMed ID: 10521437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Di-leucine signal in the ubiquitin moiety. Possible involvement in ubiquitination-mediated endocytosis.
    Nakatsu F; Sakuma M; Matsuo Y; Arase H; Yamasaki S; Nakamura N; Saito T; Ohno H
    J Biol Chem; 2000 Aug; 275(34):26213-9. PubMed ID: 10818107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A balance of opposing signals within the cytoplasmic tail controls the lysosomal targeting of P-selectin.
    Blagoveshchenskaya AD; Hewitt EW; Cutler DF
    J Biol Chem; 1998 Oct; 273(43):27896-903. PubMed ID: 9774401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoplasmic tail of invariant chain modulates antigen processing and presentation.
    Gregers TF; Nordeng TW; Birkeland HC; Sandlie I; Bakke O
    Eur J Immunol; 2003 Feb; 33(2):277-86. PubMed ID: 12548558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.